GSK to partner with Vir for potential Covid-19 treatments, invest US$250mil – The Star Online
- GSK to partner with Vir for potential Covid-19 treatments, invest US$250mil The Star Online
- GSK pumps US$250 mil into biotech firm for potential Covid-19 treatments Free Malaysia Today
- GlaxoSmithKline and Vir Biotechnology Jump in Race to Treat and Prevent COVID-19 Motley Fool
- Vir Biotechnology Soars on $250 Million GlaxoSmithKline Investment in Coronavirus Treatment TheStreet
- GSK buys $250m biotech stake in hunt for Covid-19 treatment Financial Times
- View Full coverage on Google News
Source: Business News Feed